Dialysis provider DaVita said it is collaborating with a hospital in the Yangpu District of Shanghai, China. With the support of the district government and approval of the health bureau, DaVita and Shanghai Yangpu Antu Hospital are establishing a Renal Dialysis Technology Collaboration Base at the 400-bed hospital.

Under the agreement, DaVita will provide consultation services to the public hospital on advanced management processes for its renal outpatient visits and dialysis treatments. Additionally, DaVita and the hospital will upgrade clinic technology, and expand the number of dialysis stations, DaVita said in a news release.

(DaVita income falls in third quarter)

“In support of Chinese health care reform, DaVita’s objective is to pilot a sustainable, cost-effective and high-quality renal care and dialysis network with Antu Hospital and within the Yangpu District,” said Atul Mathur, president of DaVita’s Asia-Pacific operations. “We anticipate this collaboration will serve as a model for other communities in China.”  

The arrangement provides DaVita a platform for research aimed at improving patient health outcomes and maximizing cost effectiveness for the Chinese health care system.

(LDO perspective on the bundle cuts: Consider the impact on the most vulnerable patient population in the country)

Last year DaVita entered China with a joint venture deal with 3sBio Inc., a Chinese biotechnology developer of biopharmaceutical products, to provide dialysis treatments in northeastern China.  

Find more articles about DaVita